康龙化成2025年净利16.64亿元，同比下降7.22%

Core Viewpoint - Kanglong Chemical achieved a revenue of 14.095 billion yuan in 2025, representing a year-on-year growth of 14.82%, while the net profit attributable to shareholders decreased by 7.22% to 1.664 billion yuan [1] Group 1 - The company focused on investing in automation and AI technology during the reporting period [1] - These technologies are deeply integrated into various stages of drug research and development [1] - The aim is to enhance experimental throughput, improve service efficiency, and reduce operational errors, providing clients with faster, more accurate, and reliable research data [1]